Lalit Kumar

787 total citations
34 papers, 551 citations indexed

About

Lalit Kumar is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Biology. According to data from OpenAlex, Lalit Kumar has authored 34 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmaceutical Science, 9 papers in Biomaterials and 7 papers in Molecular Biology. Recurrent topics in Lalit Kumar's work include Advanced Drug Delivery Systems (14 papers), Advancements in Transdermal Drug Delivery (13 papers) and Nanoparticle-Based Drug Delivery (8 papers). Lalit Kumar is often cited by papers focused on Advanced Drug Delivery Systems (14 papers), Advancements in Transdermal Drug Delivery (13 papers) and Nanoparticle-Based Drug Delivery (8 papers). Lalit Kumar collaborates with scholars based in India, United States and Saudi Arabia. Lalit Kumar's co-authors include Shivani Verma, Puneet Utreja, Ankur Bhardwaj, Bhuvaneshwar Vaidya, D.N. Prasad, Amit Jain, Shivani Verma, Raj Kumar Narang, R. S. R. Murthy and Vivek Gupta and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and Current Pharmaceutical Design.

In The Last Decade

Lalit Kumar

32 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lalit Kumar India 14 274 139 121 96 69 34 551
Basant Malik India 11 349 1.3× 168 1.2× 191 1.6× 77 0.8× 88 1.3× 15 664
Amirhossein Babaei Iran 15 249 0.9× 122 0.9× 84 0.7× 81 0.8× 42 0.6× 26 528
Carla Eleutério Portugal 14 207 0.8× 145 1.0× 93 0.8× 52 0.5× 46 0.7× 18 545
Riham M. El‐Moslemany Egypt 15 211 0.8× 146 1.1× 84 0.7× 45 0.5× 44 0.6× 27 616
Helen L. Alvarado Spain 13 379 1.4× 191 1.4× 90 0.7× 109 1.1× 39 0.6× 16 688
Sara Esposito Italy 10 342 1.2× 214 1.5× 130 1.1× 55 0.6× 72 1.0× 18 662
Menna M. Abdellatif Egypt 13 411 1.5× 128 0.9× 80 0.7× 83 0.9× 31 0.4× 30 664
Sharif Abdelghany Jordan 10 327 1.2× 84 0.6× 109 0.9× 138 1.4× 97 1.4× 16 545
Zaida Urbán‐Morlán Mexico 10 191 0.7× 85 0.6× 93 0.8× 95 1.0× 50 0.7× 12 480
Kailash C. Petkar India 10 302 1.1× 131 0.9× 76 0.6× 78 0.8× 35 0.5× 12 501

Countries citing papers authored by Lalit Kumar

Since Specialization
Citations

This map shows the geographic impact of Lalit Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lalit Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lalit Kumar more than expected).

Fields of papers citing papers by Lalit Kumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lalit Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lalit Kumar. The network helps show where Lalit Kumar may publish in the future.

Co-authorship network of co-authors of Lalit Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of Lalit Kumar. A scholar is included among the top collaborators of Lalit Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lalit Kumar. Lalit Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumar, Lalit, et al.. (2025). Transforming Breast Cancer Therapy: The Pivotal Role of Nanoparticles. Current Topics in Medicinal Chemistry. 26(1). 29–57. 1 indexed citations
3.
Dand, Neha, Lalit Kumar, Pankaj Wadhwa, et al.. (2023). Optimisation of a Greener-Approach for the Synthesis of Cyclodextrin-Based Nanosponges for the Solubility Enhancement of Domperidone, a BCS Class II Drug. Pharmaceuticals. 16(4). 567–567. 8 indexed citations
4.
Dand, Neha, Lalit Kumar, Pankaj Wadhwa, et al.. (2023). RP-HPLC-Based Bioanalytical Approach for Simultaneous Quantitation of Cinnarizine and Domperidone in Rat Plasma. Separations. 10(3). 159–159. 1 indexed citations
5.
Kumar, Lalit, et al.. (2022). Development and Characterization of Polymeric Microsponge as a NewVehicle to Deliver Urea Topically. Recent Patents on Nanotechnology. 17(2). 131–143. 2 indexed citations
6.
Kumar, Lalit, et al.. (2022). Exploring the Therapeutic Potential of Anticancer Heterocyclic Compounds: Role in Nanoscale Pharmacotherapy. Critical Reviews in Therapeutic Drug Carrier Systems. 40(3). 47–94. 1 indexed citations
7.
Kumar, Lalit, et al.. (2022). Overview of Inorganic Nanoparticles: An Expanding Horizon in TumorTherapeutics. Recent Patents on Anti-Cancer Drug Discovery. 18(3). 343–363. 8 indexed citations
8.
Kumar, Lalit, et al.. (2021). Nanofiber as a novel vehicle for transdermal delivery of therapeutic agents: challenges and opportunities. SHILAP Revista de lepidopterología. 7(1). 27 indexed citations
9.
Kumar, Lalit & Puneet Utreja. (2020). Transcending the Cutaneous Barrier Through Nanocarrier Exploration for Passive Delivery of Anti-hypertensive Drugs: A Critical Review. Recent Patents on Nanotechnology. 14(3). 193–209. 5 indexed citations
10.
Kumar, Lalit & Puneet Utreja. (2019). Oleic Acid Vesicles for Transdermal Delivery of Propranolol Hydrochloride: Development and Characterization. Current Drug Therapy. 15(3). 238–248. 5 indexed citations
11.
Kumar, Lalit, et al.. (2018). Advanced Drug Delivery Systems for Transdermal Delivery of Non-Steroidal Anti-Inflammatory Drugs: A Review. Current Drug Delivery. 15(8). 1087–1099. 37 indexed citations
12.
Verma, Shivani, Puneet Utreja, & Lalit Kumar. (2018). Role of Nanomedicine in Treatment of Brain Cancer. 10(2). 105–129. 2 indexed citations
13.
Kumar, Lalit, Shivani Verma, Sanjeev Kumar, D.N. Prasad, & Amit Jain. (2016). Fatty acid vesicles acting as expanding horizon for transdermal delivery. Artificial Cells Nanomedicine and Biotechnology. 45(2). 251–260. 25 indexed citations
14.
Kumar, Lalit, Shivani Verma, Bhuvaneshwar Vaidya, & Vivek Gupta. (2015). Exosomes: Natural Carriers for siRNA Delivery. Current Pharmaceutical Design. 21(31). 4556–4565. 31 indexed citations
15.
Kumar, Lalit, Shivani Verma, D.N. Prasad, et al.. (2014). Nanotechnology: A magic bullet for HIV AIDS treatment. Artificial Cells Nanomedicine and Biotechnology. 43(2). 71–86. 47 indexed citations
16.
Kumar, Lalit, et al.. (2013). Eradication of superficial fungal infections by conventional and novel approaches: a comprehensive review. Artificial Cells Nanomedicine and Biotechnology. 42(1). 32–46. 44 indexed citations
17.
Verma, Shivani, et al.. (2013). Oleic acid vesicles: a new approach for topical delivery of antifungal agent. Artificial Cells Nanomedicine and Biotechnology. 42(2). 95–101. 73 indexed citations
18.
Kumar, Lalit, et al.. (2013). Polymeric microparticles-based formulation for the eradication of cutaneous candidiasis: development and characterization. Pharmaceutical Development and Technology. 19(3). 318–325. 15 indexed citations
19.
Bhardwaj, Ankur, Lalit Kumar, Raj Kumar Narang, & R. S. R. Murthy. (2012). Development and characterization of ligand-appended liposomes for multiple drug therapy for pulmonary tuberculosis. Artificial Cells Nanomedicine and Biotechnology. 41(1). 52–59. 34 indexed citations
20.
Kumar, Rajeev, Lalit Kumar, Nand Lal, et al.. (2010). Arylpiperazines for Management of Benign Prostatic Hyperplasia: Design, Synthesis, Quantitative Structure−Activity Relationships, and Pharmacokinetic Studies. Journal of Medicinal Chemistry. 54(1). 302–311. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026